◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

AGIOS PHARMACEUTICALS, INC.

CIK: 1439222 SIC: 2834
$54.03M
Revenue
$-412.78M
Net Income
88.26%
Gross Margin
-873.87%
Op. Margin
$-679.80M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 14 of 38 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $19.97M $12.88M $12.46M $8.73M $10.73M $8.96M $8.62M $8.19M $7.10M $7.40M $6.71M $5.61M $4.31M $3.52M
Revenue Growth % (YoY) 86.1% 43.7% 44.6% 6.6% 51.1% 21.2% 28.4% 46.0% 64.8% 110.4% nan% nan% nan% nan%
Cost of Revenue $1.88M $1.68M $1.70M $1.08M $1.26M $783.00K $1.50M $627.00K $586.00K $633.00K $1.11M $554.00K $413.00K $517.00K
+ Gross Profit $18.09M $11.20M $10.75M $7.64M $9.47M $8.18M $7.12M $7.56M $6.52M $6.77M $5.60M $5.05M $3.90M $3.00M
Gross Margin % 90.6% 87.0% 86.3% 87.6% 88.3% 91.3% 82.6% 92.3% 91.7% 91.4% 83.5% 90.1% 90.4% 85.3%
Operating Expenses $141.54M $129.75M $139.51M $115.36M $135.77M $111.78M $114.43M $100.26M $113.38M $108.30M $100.41M $96.22M $103.48M $94.61M
Research & Development $88.06M $86.80M $91.94M $72.74M $82.81M $72.45M $77.40M $68.62M $77.49M $81.84M $68.89M $67.30M $70.30M $64.97M
Selling General & Admin $51.61M $41.27M $45.87M $41.53M $51.70M $38.54M $35.54M $31.01M $35.30M $25.82M $30.41M $28.37M $32.77M -
+ Operating Income $-121.58M $-116.87M $-127.06M $-106.63M $-125.04M $-102.81M $-105.82M $-92.07M $-106.28M $-100.90M $-93.70M $-90.61M $-99.17M $-91.09M
Operating Margin % -608.9% -907.4% -1020.1% -1222.0% -1165.3% -1146.9% -1228.3% -1124.3% -1496.2% -1363.7% -1396.0% -1615.5% -2301.0% -2590.7%
Other Income/Expense $113.00K $67.00K $523.00K $1.25M $1.62M $1.65M $1.58M $1.63M $1.71M $1.20M $1.64M $1.50M $1.36M $1.08M
Income Before Tax $-109.06M $-103.43M - - $-105.40M $1.00B - - $-95.94M - - - - -
Income Tax Expense $-1.02M - - - $-8.88M $53.12M - - - - - - - -
+ Net Income $-108.04M $-103.43M $-112.02M $-89.29M $-96.52M $947.91M $-96.12M $-81.55M $-95.94M $-91.32M $-83.81M $-81.02M $36.53M $-81.75M
Net Margin % -541.1% -803.1% -899.4% -1023.3% -899.6% 10574.7% -1115.7% -995.8% -1350.7% -1234.3% -1248.6% -1444.4% 847.5% -2325.0%
Basic EPS -1.85 -1.78 -1.93 -1.55 -1.72 16.65 -1.69 -1.45 -1.72 -1.64 -1.51 -1.47 0.67 -1.49
Diluted EPS -1.85 -1.78 -1.93 -1.55 -1.74 16.22 -1.69 -1.45 -1.72 -1.64 -1.51 -1.47 0.67 -1.49
Basic Shares Outstanding - 58.1M 57.9M 57.5M 98K 56.9M 56.8M 56.4M 92K 55.8M 55.6M 55.3M 55K 54.8M
Diluted Shares Outstanding - 58.1M 57.9M 57.5M 308K 58.4M 56.8M 56.4M 92K 55.8M 55.6M 55.3M 55K 54.8M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $89.13M $92.71M $80.87M $78.96M $76.25M $253.73M $84.52M $118.76M $88.20M $64.33M $84.75M $104.14M $139.26M $122.45M
Inventory $32.92M $32.03M $30.85M $29.61M $27.62M $26.43M $23.94M $23.07M $19.08M $17.27M $15.67M $11.37M $8.49M $5.18M
Other Current Assets $44.13M $43.19M $44.69M $42.29M $40.16M $39.88M $34.54M $39.11M $35.02M $38.41M $36.75M $39.30M $38.95M $46.49M
Total Current Assets $942.05M $1.03B $1.02B $968.62M $965.60M $1.07B $632.13M $663.63M $833.84M $704.35M $757.24M $791.66M $832.77M $784.93M
Property Plant & Equipment $10.78M $10.68M $10.58M $11.07M $11.68M $11.82M $12.73M $14.12M $15.38M $16.79M $19.63M $21.44M $22.99M $25.44M
Other Non-current Assets $3.93M $3.93M $3.94M $4.72M $4.72M $4.06M $4.06M $4.06M $4.06M $4.06M $4.06M $3.96M $3.96M $3.90M
Total Assets $1.30B $1.39B $1.47B $1.56B $1.66B $1.79B $773.06M $849.71M $937.12M $1.01B $1.09B $1.15B $1.24B $1.18B
Accounts Payable $18.36M $19.55M $17.53M $13.73M $16.64M $17.14M $10.04M $11.15M $9.78M $13.27M $11.63M $8.66M $18.62M $10.41M
Accrued Liabilities $45.46M $37.22M $35.29M $20.76M $46.86M $33.31M $36.74M $25.13M $43.17M $30.49M $29.19M $22.46M $30.35M $29.76M
Total Current Liabilities $82.21M $74.76M $70.41M $52.37M $81.16M $119.45M $62.64M $51.69M $67.95M $58.42M $55.14M $45.11M $62.63M $53.60M
Other Non-current Liabilities $90.00K $90.00K $101.00K $880.00K $880.00K $1.16M $1.16M $1.16M $1.16M $1.16M $1.16M $1.31M $3.28M $1.05M
Total Liabilities $104.11M $101.38M $101.68M $88.99M $122.24M $165.12M $112.55M $105.79M $126.10M $120.42M $120.92M $114.77M $137.90M $130.15M
Retained Earnings $-561.71M $-453.67M $-350.23M $-238.21M $-148.92M $-52.40M $-1.00B $-904.20M $-822.65M $-726.71M $-635.38M $-551.58M $-470.56M $-507.09M
Treasury Stock $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M $802.49M
Total Stockholders Equity $1.19B $1.28B $1.37B $1.47B $1.54B $1.63B $660.51M $743.92M $811.02M $886.84M $964.24M $1.04B $1.10B $1.05B
Total Liabilities & Equity $1.30B $1.39B $1.47B $1.56B $1.66B $1.79B $773.06M $849.71M $937.12M $1.01B $1.09B $1.15B $1.24B $1.18B
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-108.04M $-103.43M $-201.31M $-89.29M $-96.52M $947.91M $-96.12M $-81.55M $-95.94M $-256.15M $-83.81M $-81.02M $36.53M $-81.75M
Stock-based Compensation $14.12M $38.43M $26.05M $11.36M $10.90M $31.94M $20.80M $9.23M $13.81M $30.95M $21.88M $10.14M $11.46M $37.83M
Change in Receivables $5.55M $920.00K $877.00K $-765.00K $991.00K $308.00K $952.00K $643.00K $1.63M $-1.03M $45.00K $-428.00K $388.00K -
Change in Inventory $886.00K $4.42M $3.23M $1.99M $1.19M $7.35M $4.86M $3.99M $1.80M $8.78M $7.18M $2.88M $3.32M $5.18M
Change in Payables $-1.15M $2.89M $1.08M $-2.82M $-756.00K $7.36M $268.00K $1.43M $-3.53M $-5.20M $-6.84M $-9.80M $8.06M $-4.63M
Operating Cash Flow $-96.21M $-276.76M $-188.61M $-111.49M $-133.17M $-256.67M $-172.46M $-99.87M $-72.49M $-223.57M $-161.93M $-95.18M $-66.16M $-243.31M
Capital Expenditure $1.12M $3.20M $1.64M $766.00K $967.00K $718.00K $299.00K $141.00K $234.00K $765.00K $396.00K $399.00K $113.00K $4.77M
Investing Cash Flow $90.08M $287.11M $191.55M $112.59M $-49.16M $412.60M $161.81M $124.56M $95.51M $144.06M $104.72M $57.60M $82.95M $160.31M
Stock Repurchased - - - - - - - - - - - - - -
Financing Cash Flow $2.56M $6.12M $1.68M $1.62M $4.84M $9.60M $6.96M $5.86M $847.00K $4.59M $2.70M $2.47M $22.00K $2.33M
Net Change in Cash $-3.58M $16.46M $4.62M $2.72M $-177.48M $165.53M $-3.69M $30.56M $23.87M $-74.93M $-54.51M $-35.12M $16.81M $-80.68M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $12.88M - $34.06M -
Cost of Revenue $1.68M - $4.47M -
Operating Expenses $129.75M - $384.62M -
Research & Development $86.80M - $251.48M -
Selling General & Admin $41.27M - $128.67M -
Operating Income $-116.87M - $-350.55M -
Other Income/Expense $67.00K - $1.84M -
Income Before Tax $-103.43M - $-304.74M -
Income Tax Expense - - - -
Net Income $-103.43M $-96.12M $-304.74M -
Basic EPS -1.78 - -5.27 -
Diluted EPS -1.78 - -5.27 -
Basic Shares Outstanding $58.14M - $57.85M -
Diluted Shares Outstanding $58.14M - $57.85M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $92.71M $76.25M
Inventory $32.03M $27.62M
Other Current Assets $43.19M $40.16M
Total Current Assets $1.03B $965.60M
Property Plant & Equipment $10.68M $11.68M
Other Non-current Assets $3.93M $4.72M
Total Assets $1.39B $1.66B
Accounts Payable $19.55M $16.64M
Accrued Liabilities $37.22M $46.86M
Total Current Liabilities $74.76M $81.16M
Other Non-current Liabilities $90.00K $880.00K
Total Liabilities $101.38M $122.24M
Retained Earnings $-453.67M $-148.92M
Treasury Stock $802.49M $802.49M
Total Stockholders Equity $1.28B $1.54B
Total Liabilities & Equity $1.39B $1.66B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-103.43M $-96.12M $-304.74M -
Stock-based Compensation - - $38.43M -
Change in Receivables - - $920.00K -
Change in Inventory - - $4.42M -
Change in Payables - - $2.89M -
Operating Cash Flow - - $-276.76M -
Capital Expenditure - - $3.20M -
Investing Cash Flow - - $287.11M -
Financing Cash Flow - - $6.12M -
Net Change in Cash - - $16.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...